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BRIEF DEFINITIVE REPORT preabsorbed with extracts of Escherichia coli strain RY 1089 X gt 11 lysogen to remove IgE directed against those proteins that would otherwise interfere with the screening of the cDNA library. Production and Screening of cDNA Library to D. pteronyssinus Mites. mRNA from live mites was prepared using guanidine isothiocyanate extraction and affinity purified using oligodT-cellulose (no. 20003 ; Collaborative Research, Lexington, MA) (7) . A cDNA library was prepared in X gt 11 (cDNA kit no. RPN 1256 ; Amersham Corp., Arlington Heights, IL) according to the manufacturer's directions. The primary cDNA library of 1 .7 x 10 5 recombinants was amplified to generate a high titre stock. The library was immunoscreened (_105 PFU/plate) using serum pooled from mite-allergic subjects following the Amersham protocol . IgE-binding clones were detected using ' 251-labeled anti-human IgE antibodies and autoradiography and were purified to single plaques.
Purified recombinant bacteriophage representing the IgE-binding clones were used to infect E. coli strain Y1089 to produce fusion polypeptides (8) . The IgE-binding polypeptides were identified on protein blots of the lysogen extracts by probing with mite-allergic serum as above . Large scale preparation of the fusion polypeptides was carried out (8) .
Identification of the Native Allergen that Shares IgE-binding Determinants with the Cloned Protein. Electroblotting of unreduced mite extracts after SDS-PAGE on 9-2717o gradient gels (SE-400 ; Hoeffer Scientific Instruments, San Francisco, CA) was performed as previously described (2) . The inclusion bodies derived from the phage-infected E. coli lysogen containing the recombinant protein were solubilized in 2 .5o7o SDS, 100 mM DTT, 20 mM Tris, pH 7 .5, 10 mM EDTA, and 1 mM PMSF by heating at 100°C for 30 min, and were separated on 18% homogeneous gels (Mini-Protean II apparatus ; Bio-Rad Laboratories, Richmond, CA) . Each blot of mite bodies and inclusion bodies were divided into two portions, and one portion was stored at 4'C . The remaining portion was incubated in l0 5 Jo pooled mite-atopic serum in PBS, 0 .1% sodium azide overnight . The position of IgE-binding components on the blots were located using narrow vertical strips cut from each edge of the blot after incubated with " 5 I-anti-IgE and autoradiography. The major IgE-binding horizontal band (N30-40 mm long x 2-3 mm wide) was excised from blot of inclusion bodies, and six major IgE-binding bands were excised from the blot of mite bodies . An additional strip that did not bind IgE was also excised from the bottom of each blot to function as a control . Each strip was cut into pieces _2 mm 2 and IgE was eluted by six cycles of gentle vortexing for 1 min each with 100 /Al of 0 .1 M Glycine-HCI, pH 2 .5, 1% (wt/vol) BSA, followed by immediate neutralization with a 3 M Tris-HCl solution, pH 8 .8, to give a final pH of 7 .0 . Sodium azide was added to a final concentration of 0 .1 % (wt/vol). The solution containing the antibodies eluted from the inclusion body blot was incubated overnight with a stored strip from the mite blot . Similarly, solutions containing the IgE eluted from the six bands of the blot of mite body extract were incubated with strips from the blot of the inclusion bodies . The position of binding of the IgE was located with enzyme-labeled anti-IgE . As an additional control for specificity, IgE samples originally eluted from the blot of the inclusion bodies, after incubation with the mite blot, were then incubated with strips from the blot of the inclusion bodies . Similar controls were performed with IgE from the mite blots .
Sequencing of cDNA . DNA was prepared from the selected IgE-binding cDNA bacteriophage clone (8) and the cDNA insert excised by Eco RI digestion (7), purified after separation on low melting point agarose, and ligated into the plasmid pBTA 502 (Biotechnology, Sydney, Australia). After transformation in the E. coli strain JM109 and the isolation of transformed colonies, plasmid DNA was prepared (9) . DNA sequencing was carried out on an alkalidenatured plasmid template using a 17-mer primer (no. 1211 ; New England Biolabs, Beverly, MA) and the enzyme Sequenase (United States Biochemical Corp ., Cleveland, OH) according to the manufacturer's directions . 35 S-labeled products were run on 8% polyacrylamide gels for 2 and 4 h, autoradiographed overnight, and the sequence of the first 250 bases was determined . For further sequencing, a set of nested deletions was created using the "Erase-a-base" Exo III/S1 nuclease system (Promega Biotec, Madison, WI) .
Results
Identification ofthe Mite Component Corresponding to the Recombinant Mite Protein . Blots of the bacterial inclusion bodies containing the recombinant mite fusion protein showed a major IgE-binding component of mol wt "150,000 (Fig. 1 b) , whereas blots of nonrecombinant bacterial lysate did not bind IgE (not shown) . IgE eluted from this component on an excised portion of the recombinant blot ( Fig. 1 b, position 1) , when incubated with a strip from a blot of mite extract, bound to a component of mol wt ti 14,000 (Fig. 1 e) . The position on the gels of the component of mol wt 14,000 was of a mol wt ti 1,000 less than Derp II. The same procedure was carried out with the control non-IgE-binding portion of inclusion body blot ( Fig . 1 b, position 2 ) and no binding of IgE to the mite blot was detected (not shown) . When, after incubation with the mite blots, these eluates were reincubated with recombinant blots, the eluted IgE only bound to the inclusion body component of mol wt ti 150,000 (not shown) . Similarly, when IgE eluted from the major IgE-binding bands of a mite blot (Fig . 1 d, positions 1-6 ) and a seventh control position (not shown) were incubated with strips from the inclusion body blot, strong IgE binding was only detected with IgE eluted from position 6 of the mite strip ( Fig. 1 f) and not with IgE eluted from other positions (not shown) . When the eluted IgE was reincubated with mite strips, with one exception, each fraction only bound to the component it was eluted from (results not shown) . The exception was IgE eluted from the component of mol wt 30,000, which bound to the components of mol wt 30,000, and to a lesser extent to the component of mol wt 25,000 (not shown) .
Sequence of the cDNA. The cDNA sequence and the deduced amino acid sequence derived from the cDNA insert is shown in Fig. 2 . The insert corresponds to a 148-amino acid polypeptide of estimated mol wt 17,460 and contains no cysteine or tryptophan . At the level of 20 matched bases no homology was found between this sequence and other DNA sequences using the Integenetics IFIND programme (ItelliGenetics, Inc., Mountain View, CA) to search the NIH database. Nucleotide and predicted amino acid sequence of the cDNA whose expression product shares the IgE-binding determinants with a component of mite extracts of mol wt -14,000 . The numbers at the right refer to amino acid positions . These sequence data have been submitted to the EMBL/GenBank Data Libraries .
Comparison ofIgE Binding to Blots of the Recombinant Mite Protein and the Corresponding
Component ofMite Extracts.
Of the 38 sera tested, 16 did not bind to either the region of the recombinant blot corresponding to components of 150,000 or the region of the mite blots corresponding to mol wt 14,000, two bound weakly to the mite blot only and five bound weakly to the recombinant blot only. All of the remaining 15 sera bound with similar intensities to both blots.
Discussion
The results demonstrate the cloning of an IgE-binding recombinant mite polypeptide recognized by about half the sera from a mite-allergic group of subjects tested . A similar frequency of recognition for the corresponding component on mite blots has been demonstrated in other protein blotting studies from this laboratory using a greater number of sera (4). This component is one of six, of the total of >30, suggested to be important allergens of D. pteronyssinus (2, 4) .
The blotting strategy used here to identify proteins extracted from a native source carrying the same IgE-binding determinants as the cloned inclusion polypeptides should be generally applicable to the cloning of other allergens. The specificity of the antibody recognition was maximized by the following approaches . The sera used were preabsorbed with a lysate of E. coli infected with the phage lacking the cDNA insert to eliminate the possibility of IgE binding to E. coli proteins . The IgE was eluted from blots of both the native material and the recombinant polypeptides and then bound to blots of the recombinant polypeptides and native material, respectively. The eluted IgE was shown to faithfully bind to the original blotted source .
The precise molecular weight of the native mite component corresponding to the recombinant protein was not determined . On unreduced SDS-PAGE gels the component had a mol wt of "14,000, -1,000 less than the allergen Der p II . Der p II has a mol wt of 15,000-16,000 by SDS-PAGE, and a mol wt of 14,131 based on amino acid analysis . Differences between molecular weight values based on electrophoretic migration on SDS-PAGE and sequence data are not uncommon (10) and such discrepancies are more pronounced for low molecular weight proteins (11) .
From the predicted amino acid sequence, the molecular weight of the cloned mite allergen is -3,000 greater than the molecular weight determined by nonreducing SDS-PAGE for the corresponding blotted mite component. It may be that the native (mature) component in mite extracts lacks some of the terminal amino acids present in the recombinant protein. A possibility may be the leader sequence, usually of 19-21 amino acids associated with proteins made on membrane-bound ribosomes and normally cleaved off post-translationally during membrane transport (12) . The deduced amino acid sequence from a cDNA clone of Der p I was demonstrated to contain an additional 23 amino acids when compared with the amino acid sequence of native Der p I purified from mite extracts (5) .
The strong correlation between the intensity and specificity of binding of IgE from a panel of sera to the electroblotted blotted recombinant protein, and a component of mol wt -14,000 on blots of the native mite extract, suggests a potential use of such recombinant material for specific diagnostic applications . An aim of the approach described here is to assemble a panel of mite recombinant proteins that include all of the important IgE-binding determinants . Such a selected panel may be more amenable to standardization than the highly variable crude extracts currently available from native sources. Cloned allergens may also be more amenable to modifications, making them safer and more suitable for immunotherapy. Considering the slow progress isolating individual allergens to date, recombinant DNA methods may offer great potential for the future production and sequencing of allergens and for the identification of allergenic determinants .
Summary
A cDNA clone coding for a mite allergen of mol wt -14,000 has been isolated and its DNA sequence determined . The native component from mite extracts encoded by this DNA was identified by immunoprobing blots of mite body extract with human IgE eluted from the electroblotted cloned fusion polypeptides derived from the expressed cDNA clone. The clone encodes a polypeptide with a deduced mol wt of 17,460 . The deduced amino acid sequence was not homologous to any known protein sequences and it contains no cysteine or tryptophan . On blots, 21 of 38 sera from mite-allergic subjects recognized the cloned material, and this recognition strongly correlated with IgE-binding to the native component on protein blots of mite extract.
